US Patent Issued to Venatorx Pharmaceuticals on Feb. 24 for "Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereof" (Pennsylvania Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,509, issued on Feb. 24, was assigned to Venatorx Pharmaceuticals Inc. (Malvern, Pa.).

"Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereof" was invented by David P. Dickson (Merion Station, Pa.), Anthony Drager (Thorndale, Pa.), Gopinath Rongala (Malvern, Pa.) and Allison L. Zulli (Chesterbrook, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a compound that is (R)-(2-(3-((((2-ethylbutanoyl)oxy)methoxy)carbonyl)-2-hydroxyphenyl)-1-propionamidoethyl)boronic acid citrate coordination complex, or a pharmaceutically acceptable salt or solvate thereof. Also disclosed herein are methods of t...